Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20+ Follicular Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06703892
What this trial is testing

Evaluate the Safety and Clinical Activity of GF- CART01 (CD20/19 CAR T Cell) in Subjects With Relapsed or Refractory B-Cell Hematological Malignancies

Who this might be right for
Diffuse Large B Cell Lymphoma RelapsedDiffuse Large B Cell Lymphoma RefractoryFollicular Lymphoma ( FL)+3 more
GenomeFrontier Therapeutics TW Co., Ltd. 18
Testing effectiveness (Phase 2)Ended earlyNCT05360238
What this trial is testing

Study to Assess Safety, Tolerability and Efficacy of MB-106 in Patients With Relapsed or Refractory B-Cell NHL or CLL

Who this might be right for
Follicular B-cell Non-Hodgkin's LymphomaMantle Cell Lymphoma RecurrentMantle Cell Lymphoma Refractory+5 more
Mustang Bio 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05100862
What this trial is testing

Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

Who this might be right for
Relapsed/Refractory Follicular LymphomaMarginal Zone Lymphoma
BeOne Medicines 799
Early research (Phase 1)Study completedNCT00825149
What this trial is testing

Obinutuzumab in Combination With Chemotherapy in Participants With CD20+ B-Cell Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 137
Early research (Phase 1)Study completedNCT03019666
What this trial is testing

Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaDiffuse Large B Cell Lymphoma+5 more
Masonic Cancer Center, University of Minnesota 39
Testing effectiveness (Phase 2)Study completedNCT00003849
What this trial is testing

Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 39
Testing effectiveness (Phase 2)Study completedNCT03097770
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 100
Early research (Phase 1)Study completedNCT00561756
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 8
Large-scale testing (Phase 3)Study completedNCT03976102
What this trial is testing

Compare Efficacy, Safety, and Immunogenicity of Proposed Rituximab Biosimilar (DRL_RI) With MabThera® in LTB Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Dr. Reddy's Laboratories Limited 317
Early research (Phase 1)Ended earlyNCT00033423
What this trial is testing

Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Alabama at Birmingham 18
Early research (Phase 1)Study completedNCT00621452
What this trial is testing

Genetically Engineered Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or Indolent B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell Lymphoma+8 more
Fred Hutchinson Cancer Center 12
Large-scale testing (Phase 3)Ended earlyNCT00384111
What this trial is testing

Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL)

Who this might be right for
Follicular LymphomaLymphoma, Follicular
Spectrum Pharmaceuticals, Inc 26
Large-scale testing (Phase 3)Study completedNCT01889069
What this trial is testing

Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL)

Who this might be right for
Lymphoma
Hoffmann-La Roche 159
Testing effectiveness (Phase 2)Active Not RecruitingNCT04962126
What this trial is testing

Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy

Who this might be right for
Follicular Lymphoma
Olivia Newton-John Cancer Research Institute 15
Early research (Phase 1)Study completedNCT00880815
What this trial is testing

Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant

Who this might be right for
CD20 PositiveChronic Lymphocytic LeukemiaFollicular Lymphoma+4 more
M.D. Anderson Cancer Center 60
Not applicableActive Not RecruitingNCT04911478
What this trial is testing

Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells

Who this might be right for
Lymphoma, FollicularLymphoma, Mantle-CellMarginal Zone Lymphoma+3 more
Adicet Therapeutics 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04889716
What this trial is testing

CAR-T Followed by Bispecific Antibodies

Who this might be right for
Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Abramson Cancer Center at Penn Medicine 23
Early research (Phase 1)Study completedNCT00720135
What this trial is testing

Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Anaplastic Large Cell LymphomaCutaneous B-cell Non-Hodgkin LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+11 more
City of Hope Medical Center 9
Not applicableStudy completedNCT05529524
What this trial is testing

Signatures of Response and Resistance to Mosunetuzomab in Follicular Lymphomas (FL)

Who this might be right for
Follicular Lymphoma
The Lymphoma Academic Research Organisation 6
Large-scale testing (Phase 3)Looking for participantsNCT06091254
What this trial is testing

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma

Who this might be right for
Follicular Lymphoma (FL)
Regeneron Pharmaceuticals 822
Next Page